-
MARKET SHARE AND ECONOMIC TRENDS OF JANUS KINASE INHIBITORS IN U.S. MEDICAID, 2011- 2023
Feb 25, 2026, 14:43 PM -
COST EFFECTIVENESS ANALYSIS OF OBINUTUZUMAB? VERSUS CYCLOSPORINE A IN THE TREATMENT OF PRIMARY MEMBRANOUS NEPHROPATHY
Feb 25, 2026, 14:43 PM -
PATIENT-MODIFIABLE RISK FACTORS FOR ANASTOMOTIC LEAK IN COLORECTAL SURGERY: A SCOPING REVIEW
Feb 25, 2026, 14:43 PM -
EVALUATING THE QUALITY OF CLINICAL EVIDENCE FOR DIGITAL HEALTH SOLUTIONS ACROSS FIVE THERAPEUTIC AREAS: FINDINGS FROM PHTI ASSESSMENTS
Feb 25, 2026, 14:43 PM -
EVALUATING THE COST EFFECTIVENESS OF HPV VACCINATION IN EGYPT
Feb 25, 2026, 14:43 PM -
REAL-WORLD RELIABILITY AND VALIDITY OF THE EQ-5D-5L IN CHINESE PATIENTS WITH DIABETIC KIDNEY DISEASE: A CROSS-SECTIONAL STUDY
Feb 25, 2026, 14:43 PM -
QUALITY FIRST: MODERNIZING THE NURSING CURRICULUM FOR ACCREDITED HEALTHCARE
Feb 25, 2026, 14:43 PM -
OPEN ORGANIZATIONAL INNOVATION IN PUBLIC HEALTH: EVIDENCE FROM BRAZILIAN HOSPITALS AND A FRAMEWORK FOR SCALABLE, VALUE-GENERATING IMPLEMENTATION
Feb 25, 2026, 14:43 PM -
MATCHING-ADJUSTED INDIRECT COMPARISON AND COST-UTILITY OF ZORIFERTINIB VERSUS OSIMERTINIB IN TREATING NEWLY DIAGNOSED EGFR-MUTANT NSCLC WITH CNS METASTASES IN CHINA
Feb 25, 2026, 14:43 PM -
ECONOMIC BURDEN AND USE OF GLUCOSE-LOWERING MEDICATIONS IN U.S. ADULTS WITH DIABETES, BY CARDIOVASCULAR-KIDNEY-METABOLIC COMPONENTS: 2012-2021
Feb 25, 2026, 14:43 PM -
ECONOMIC BURDEN AND BARRIERS ASSOCIATED WITH EARLY DIAGNOSIS OF BREAST CANCER IN THE UNITED STATES: A SYSTEMATIC LITERATURE REVIEW (SLR)
Feb 25, 2026, 14:43 PM -
COST-EFFECTIVENESS OF PROCALCITONIN-GUIDED ANTIBIOTIC THERAPY IN ADULT PATIENTS WITH ACUTE RESPIRATORY INFECTION IN A COLOMBIAN REFERRAL HOSPITAL
Feb 25, 2026, 14:43 PM -
HETEROGENEOUS REAL-WORLD EFFECTS OF FOOD ENVIRONMENT INTERVENTIONS ON OBESITY: TESTING THE EXHAUSTED MARGIN HYPOTHESIS
Feb 25, 2026, 14:43 PM -
SIX MONTH OUTCOMES AND GLUCAGON-LIKE PEPTIDE-1 (GLP-1) THERAPY PERSISTENCE AMONG COMMERCIALLY INSURED ADULTS WITHOUT DIABETES IN AN OBESITY CARE MANAGEMENT PROGRAM
Feb 25, 2026, 14:43 PM -
BIREOCICLIB PLUS FULVESTRANT FOR HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS
Feb 25, 2026, 14:43 PM -
UNDERSTANDING THE GLOBAL ECONOMIC BURDEN OF HEPATITIS DELTA VIRUS: A SYSTEMATIC LITERATURE REVIEW
Feb 25, 2026, 14:43 PM -
BAYESIAN MULTI-PARAMETER EVIDENCE SYNTHESIS FOR INFORMED INDIRECT TREATMENT COMPARISONS OF EXTRAPOLATED SURVIVAL OUTCOMES
Feb 25, 2026, 14:43 PM -
NURSE STAFFING RATIOS AND PATIENT OUTCOMES IN PENNSYLVANIA: POLICY IMPLICATIONS AND HOSPITAL COSTS
Feb 25, 2026, 14:43 PM -
ECONOMIC AND CLINICAL OUTCOMES OF CELL-BASED VERSUS EGG-BASED INFLUENZA VACCINES IN U.S. PEDIATRIC AND ADULT POPULATIONS: A MODELING STUDY
Feb 25, 2026, 14:43 PM -
IMPACT OF ETEPLIRSEN TREATMENT INITIATION DELAYS ON LOSS OF AMBULATION INCIDENCE AMONG AMBULATORY PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY
Feb 25, 2026, 14:43 PM
